Atara Biotherapeutics (ATRA) Change in Account Payables (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Change in Account Payables of $510000.0 for Q1 2026, up 367.02% on a QoQ basis from -$191000.0 in Q4 2025, and up 117.1% year-over-year from $234918.2 in Q1 2025.
Atara Biotherapeutics (ATRA) Change in Account Payables (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Change in Account Payables history runs 14 years deep, the most recent figure standing at $510000.0 for Q1 2026.
- Quarterly Change in Account Payables rose 117.1% year-over-year to $510000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$747000.0 (up 49.18% YoY) and the FY2025 annual result came in at -$4.2 million, down 717.18% from the prior year.
- Change in Account Payables was $510000.0 for Q1 2026 at Atara Biotherapeutics, up from -$191000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.5 million in Q3 2023 and bottomed at -$4.6 million in Q1 2022.
- A 5-year average of -$904941.2 and a median of -$894000.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables plunged 1346.78% — and 2024, when it jumped 368.34%.
- Atara Biotherapeutics' Change in Account Payables stood at -$4.5 million in 2022, then surged by 36.85% to -$2.8 million in 2023, then jumped by 179.12% to $2.2 million in 2024, then slumped by 108.59% to -$191000.0 in 2025, then soared by 367.02% to $510000.0 in 2026.
- Business Quant data shows ATRA's Change in Account Payables at $510000.0 in Q1 2026, -$191000.0 in Q4 2025, and -$983000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | 510,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 510,000.00 |
| Mar 31, 2026 | 510,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Dec 31, 2025 | -191,000.00 |
| Sep 30, 2025 | -983,000.00 |
| Sep 30, 2025 | -983,000.00 |
| Jun 30, 2025 | -83,000.00 |
| Jun 30, 2025 | -83,000.00 |
| Mar 31, 2025 | -2.98 Mn |
| Mar 31, 2025 | -2.98 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | -3.11 Mn |
| Sep 30, 2024 | -3.11 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | -826,000.00 |
| Mar 31, 2024 | -826,000.00 |
| Dec 31, 2023 | -2.81 Mn |
| Dec 31, 2023 | -2.81 Mn |